Management of angina involves a multifaceted approach that includes lifestyle modifications, medications, and, in some cases, medical procedures. Making lifestyle adjustments frequently revolves around embracing a diet that promotes heart health, participating in consistent physical activity, quitting smoking, and effectively managing stress.. Medications may include nitroglycerin to provide immediate relief during angina episodes, beta-blockers to reduce heart rate and blood pressure, and antiplatelet agents to prevent blood clot formation. Additionally, statins may be prescribed to lower cholesterol levels and improve overall cardiovascular health. In cases where medication and lifestyle changes are insufficient, interventions such as angioplasty or coronary artery bypass grafting (CABG) may be considered to restore blood flow to the heart. Regular medical monitoring and follow-up are essential components of angina management to adjust treatment plans as needed and prevent complications, providing individuals with a comprehensive and tailored approach to their cardiovascular health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India